HCPCS Level II S8948: Low-Level Laser Therapy, Provider-Attended, per 15 Minutes
HCPCS Level II code S8948 represents time-based, clinician-attended low-level laser therapy delivered in 15-minute increments. The code is used to report services where a provider must be continuously present to operate the laser modality on one or more treatment areas. Nationally, this code matters because it captures a specific modality of therapeutic intervention that often appears on outpatient physical medicine and rehabilitation service lines and can affect billing workflows, coverage determinations, and utilization tracking.
Key payers in the analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise review of the code’s clinical context, typical sites of service, common billing modifiers, and payor coverage patterns where available. The publication summarizes benchmark metrics and policy considerations relevant to outpatient therapy and device-based modalities when data are present. It also flags areas where data are not available in the input.
This report is intended for billing managers, reimbursement analysts, and clinical leaders seeking a national-level reference for coding and administrative classification of provider-attended low-level laser therapy.
Customize your policy alerts
Sign up for hcpcs S8948 policy alerts
Get alerted when payer policies referencing S8948 are released or updated.
Monitor payer policy activity
Billing Code Overview
HCPCS Level II code S8948 describes the application of a modality requiring constant provider attendance to one or more areas; low-level laser; each 15 minutes. This service involves direct, continuous clinician supervision and operation of a low-level laser device to targeted anatomical areas for therapeutic purposes.
-
Service type: Low-level laser therapy with continuous provider attendance
-
Typical site of service: Outpatient clinic, physician office, outpatient rehabilitation facility, or other ambulatory care settings where clinician-attended therapeutic modalities are delivered